Jennifer Sipos, MDThe James Cancer Center
- Endocrinology, Diabetes & Metabolism
- Diabetes Mellitus
- Thyroid Diseases
- Thyroid Cancer
- Thyroid Nodule
- Multiple Endocrine Neoplasia Type 2a
- Multiple Endocrine Neoplasia Type 2b
Make an Appointment
I’m an endocrinologist treating patients with thyroid cancer and thyroid nodules. At The Ohio State University, I serve as director of the Benign Thyroid Disorders Program in the Division of Endocrinology, where I am also a professor. My research interests include management of iodine-refractory thyroid cancer and salivary damage after radioiodine therapy. Additionally, I’m proficient in speaking medical Spanish.
I’m involved in several research projects and clinical trials, serving as principal investigator on three studies. I’ve been published in a variety of peer-reviewed medical journals and have presented my findings and lectured all over the United States and internationally in India, Brazil, Argentina, Canada, Italy, France and Puerto Rico.
I feel privileged to be part of The Ohio State University and I’m especially proud to contribute to the work we do here at the OSUCCC – James. By providing cutting-edge research and delivering superior, individualized care to each and every one of our patients, we aim to create a cancer-free world.
Education and Background
Wake Forest University School of Medicine
Wake Forest Baptist Medical Center
Winston Salem, NC
University of North Carolina Hospitals
- American Board of Internal Medicine
- American Board of Internal Medicine (Subspecialty: Endocrinology, Diabetes & Metabolism)
- Department of Internal Medicine
- Division of Endocrinology and Metabolism
I see patients at
The James at Martha Morehouse Medical Plaza
2050 Kenny Road, Columbus, Ohio 43221
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Sipos has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.
- Genzyme Corporation